The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Gilead Sciences, Inc shares valued at $1,136,300 were sold by O’Day Daniel Patrick on Aug 28 ’25. At $113.63 per share, O’Day Daniel Patrick sold 10,000 shares. The insider’s holdings dropped to 595,725 shares worth approximately $67.31 million following the completion of this transaction.
Also, DANIEL O’DAY purchased 10,000 shares, netting a total of over 1,136,300 in proceeds.
Before that, Mercier Johanna had sold 28,000 shares from its account. In a trade valued at $3,318,927, the Chief Commercial Officer traded Gilead Sciences, Inc shares for $118.53 each. Upon closing the transaction, the insider’s holdings decreased to 28,000 shares, worth approximately $12.9 million.
As published in a research note from Daiwa Securities on August 19, 2025, Gilead Sciences, Inc [GILD] has been rated up from a Neutral to an Outperform and the price target has been revised to $128. Analysts at Truist upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early August. As of July 25, 2025, Needham has increased its “Hold” rating to a “Buy” for GILD.
Analyzing GILD Stock Performance
On last trading session, Gilead Sciences, Inc [NASDAQ: GILD] rose 0.25% to $112.99. The stock’s lowest price that day was $112.15, but it reached a high of $113.4 in the same session. During the last five days, there has been a drop of approximately -1.53%. Over the course of the year, Gilead Sciences, Inc shares have jumped approximately 42.22%. Shares of the company reached a 52-week high of $121.83 on 08/12/25 and a 52-week low of $88.57 on 01/10/25.
Support And Resistance Levels for Gilead Sciences, Inc (GILD)
According to the 24-hour chart, there is a support level at 112.29, which, if violated, would cause prices to drop to 111.60. In the upper region, resistance lies at 113.54. The next price resistance is at 114.10. RSI (Relative Strength Index) is 44.94 on the 14-day chart, showing neutral technical sentiment.
Is Gilead Sciences, Inc subject to short interest?
Stocks of Gilead Sciences, Inc saw a sharp steep in short interest on 2025-08-15 dropping by -4.31 million shares to 18.23 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 22.54 million shares. A decline of -23.66% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.92 of the overall float, the days-to-cover ratio (short ratio) decline to 2.92.
Which companies own the most shares of Gilead Sciences, Inc (GILD)?
In terms of Gilead Sciences, Inc share price expectations, FactSet research, analysts set an average price target of 126 in the next 12 months, up nearly 11.79% from the previous closing price of $112.71. Analysts anticipate Gilead Sciences, Inc stock to reach 143 by 2025, with the lowest price target being 108. In spite of this, 17 analysts ranked Gilead Sciences, Inc stock as Buy at the end of 2025. On March 04, 2025, Oppenheimer assigned a price target of “an Outperform” to the stock and reiterated coverage with a $132.
